Explore more publications!

Guinea Bissau Health Bulletin: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Guinea Bissau Health Bulletin.

Press releases published on November 5, 2025

Ambio Life Sciences Launches Europe’s First Physician-Led Ibogaine Clinic
MMI Receives IDE Approval from FDA for First Robotic Microsurgical Study in Alzheimer’s Patients
Mucinex Brings Mr. Mucus to Canada for the First Time With Proven 12-Hour Cold and Flu Relief
NCPA and Arkansas Pharmacists Join Legal Fight to Preserve Law Barring Companies from Operating PBMs and Pharmacies in the State
MiNK Therapeutics to Report Third Quarter 2025 Financial Results and Highlight Clinical and Corporate Milestones Advancing iNKT Platform Toward Pivotal Development
Precision Neuroscience and SCI Ventures Partner to Bring Brain–Computer Interfaces to People Living with Paralysis
Outset Medical to Present at the 2025 Stifel Healthcare Conference
Alpha Pro Tech, Ltd. Announces Third Quarter  2025 Financial Results
NewGenDigital Appointed as SAXA Inc.’s Agent for Tokenization of US$100 Million of Gold-backed Assets
StoryMD Launches “My StoryMD Journeys,” an AI-Powered  Health Platform That Transforms an Individual’s Fragmented Medical Records into a Unified and Personalized Health Narrative
Solana Company (NASDAQ: HSDT) Releases Investor Update
Standard Dental Labs Signs Binding Agreement to Acquire Dream Dentistry Labs, LLC, Strengthening Central Florida Operations
BiomX to Report Third Quarter 2025 Financial Results and Program Updates on November 12, 2025
Project C.U.R.E. Bridge the Global Healthcare Divide with Mission-Driven Innovation with Microsoft
Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S. 
Tempest Reports Third Quarter 2025 Financial Results and Provides Business Update
iAnthus Continues Expansion in Florida with GrowHealthy Dispensary Opening in Fort Myers
YD Bio and EG BioMed Expand U.S. Access to OkaiDx™, a cfDNA‑Methylation Blood Test for Post‑Treatment Breast Cancer Monitoring
Nexalin Technology’s Q-Submission for Gen-2 SYNC Accepted by U.S. FDA for the Treatment of Alzheimer’s Disease and Dementia
Arch Biopartners Expands Phase II Cardiac Surgery-Associated AKI Trial to Include Royal Columbian Hospital in British Columbia

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions